✦ LIBER ✦

Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid

✍ Scribed by James L. Abbruzzese; Robert Amato; Susan Schmidt; Martin N. Raber; Philip Frost

Book ID: 105645883
Publisher: Springer
Year: 1990
Tongue: English
Weight: 403 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02897192

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

945 Phase I study of high dose 5-fluorou

945 Phase I study of high dose 5-fluorouracil and folinic acid in weekly continuous infusion

✍ J.M. Limacher; B. Duclos; J. Wihlm; D. Leveque; P. Dufour; F. Eichler; R. Keilin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 160 KB

High-dose intravenous zidovudine with 5-

High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trial

✍ Marshall R. Posner; James W. Darnowski; Alan B. Weitberg; Michael N. Dudley; Don 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

Phase I trial of oxaliplatin with fluoro

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

✍ Conroy, T; Viret, F; François, E; Seitz, J F; Boige, V; Ducreux, M; Ychou, M; Me 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Sequential chemotherapy with dose-dense

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial

✍ Matteo Dalla Chiesa; Gianluca Tomasello; Sebastiano Buti; Rodrigo Kraft Rovere; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB

Phase I study of 5-day continuous infusi

Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea

✍ James W. Raschko, Steven A. Akman, Lucille A. Leong… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 394 KB

Randomized phase III Study of 5-fluorour

Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer

✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized